It is important to note that the risk of reactivation of TB and other infectious granulomatous pathologies with the use of TNF inhibitors is not very high; in addition, in the case of TB development and during infectious pathology treatment, including preventive measures, treatment with TNF blockers can be continued [239,266]. The gene discussed is TNF; the disease is tuberculosis.